Cambridge Investment Research Advisors, Inc. Merck & Co., Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 464,199 shares of MRK stock, worth $46 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
464,199
Previous 442,293
4.95%
Holding current value
$46 Million
Previous $54.8 Million
3.73%
% of portfolio
0.18%
Previous 0.2%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,820Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.52 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.87 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $251B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...